YS Biopharma Highlights Interim Results Of Pivotal Phase 3 Clinical Study Of PIKA Rabies Vaccine; Says Results Indicate That The Pika Rabies Vaccine Has Successfully Met The Primary Endpoints Of The Trial
YS Biopharma強調了PIKA狂犬病疫苗的關鍵性3期臨床研究的中期結果；稱結果表明皮卡狂犬病疫苗已成功達到試驗的主要終點